The European Directive on the Legal Protection of Biotechnological Inventions, formally known as Directive 98/44/EC, represents a significant step in harmonizing the patenting of biotechnological innovations across member states of the European Union. It was adopted to clarify the legal status of biotechnological inventions and to ensure that the European patent system keeps pace with rapid advancements in biotechnology while balancing ethical, environmental, and socio-economic considerations. The Directive seeks to promote innovation in areas such as genetic engineering, pharmaceuticals, agriculture, and plant breeding, while at the same time safeguarding fundamental principles related to human dignity, biodiversity, and traditional knowledge. One of the central features of the Directive is its definition of what constitutes a patentable biotechnological invention. It affirms that biological material which is isolated from its natural environment or produced by means of a technical process may be the subject of an invention, even if it previously occurred in nature. This provision is particularly relevant in biotechnology, where the identification and isolation of genes, proteins, or microorganisms often require significant technical effort. Thus, the Directive recognizes human intervention and technical contribution as key criteria for patentability. However, it also maintains the traditional requirements of novelty, inventive step, and industrial applicability, ensuring that not all discoveries are automatically granted patent protection. In the context of plant varieties protection, the Directive carefully distinguishes between patent protection and plant variety rights. It explicitly excludes plant varieties and animal breeds from patentability, as these are protected under a separate regime, such as the Community Plant Variety Rights system and international frameworks like UPOV. However, the Directive allows patents for inventions that concern plants or animals if the technical feasibility of the invention is not confined to a particular plant or animal variety. For example, a genetically modified trait that can be introduced into multiple plant species may be patented, whereas a specific plant variety cannot. This distinction ensures that breeders retain access to genetic resources while also encouraging innovation in plant biotechnology. The Directive also addresses the protection of genetic sequences and biological material. It permits the patenting of gene sequences or partial sequences, provided that their industrial application is disclosed in the patent application. This requirement prevents the mere discovery of a gene without any known function from being